Central Trust Company’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SIMG
CAM
BTW
MMC
AT
WCM
MMA
Central Trust Company's HALO Position: Q2 2026 in Review
Central Trust Company reduced its Halozyme (HALO) stake by 21% in Q2 2026, selling an estimated $6.27K and leaving 356 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1009.
Central Trust Company first reported a position in HALO in Q2 2021 and has held it in 21 quarters since. The position peaked at $29K in Q1 2026. 236 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Central Trust Company held 356 shares of Halozyme worth $27.9K as of Q2 2026.
- Central Trust Company sold 92 Halozyme shares in Q2 2026, an estimated $6.27K.
- Halozyme made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1009 holding.
- Central Trust Company first reported a position in Halozyme in Q2 2021 and has held it in 21 quarters since.
- Central Trust Company's Halozyme position peaked at $29K in Q1 2026.
- 236 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.